Expert panel of the Chinese Society of Cardiology recommendations on beta-blocker therapy in patients undergoing non-cardiac surgery

The initiation of beta-blockers in the perioperative period of non-cardiac surgery remains controversial. After reviewing all the evidence, the expert panel of the Chinese Society of Cardiology (CSC) believes that there lacks high-quality randomized trial and the use of perioperative beta-blocker can only be considered on a case-by-case basis. Five practical recommendations are presented.

Source: European Journal of Heart Failure Supplements - September 23, 2015 Category: Cardiology Authors: Huo, Y., Shi, Z., Chen, Y., Dong, Y., Ge, J., Han, Y., He, B., He, Z., Huang, D., Li, X., Li, Y., Liao, Y., Liu, M., Lu, X., Ma, C., Ning, T., Sun, N., Wang, J., Wu, X., Yan, X., Yang, T., Yang, X., Zhang, J., Zhou, L., Zhu, W. Tags: Articles Source Type: research